Latest Breaking News On - American college of rheumatology convergence - Page 2 : comparemela.com

High-Risk Pediatric Patients With Antiphospholipid Syndrome Present Risk of Severe Health Issues

The results found that 93% of individuals in the high-risk group presented persistently positive antiphospholipid antibodies, compared with 47% of individuals in the lower-risk group.

New Risk Factor Found for Future Cardiovascular Disease in Patients With Systemic Lupus Erythematosus

Investigators found that positive antiphospholipid antibodies and traditional risk factors were associated with atherosclerotic cardiovascular disease.

John Botson, MD: Pegloticase Plus Immunomodulator Enhances Gout Treatment

John Botson, MD, discusses his study examining real-world pegloticase plus immunomodulation co-therapy using data from an insurance claims database.

Sustained Serum Urate Reduction for Gout Patients Observed with AR882

In this data shown at ACR 2023, the URAT1 inhibitor known as AR882 showed promising phase 2b data for patients with gout.

Fierce Biotech Bureau of Investigations seeks ACR poster burglar